Gail K. Boudreaux

Gail K. Boudreaux

DirectoratElevance Health· In proxies 2017–2025

Pay in FY2025+10% from the year before

Gail K. Boudreaux was paid $22.6M in FY2025 (Dec), up 10%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Elevance Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TargetPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. Elevance HealthPublic company · 9 yr
    • President and Chief Executive Officer (CEO)2017 – Present · 9 yrNo stock prices for these years
  3. DirectorPublic company
    • Director? – PresentNo stock prices for these years
  4. Central Indiana Corporate PartnershipPublic company
    • Director? – PresentNo stock prices for these years
  5. Zimmer Biomet Holdings, Inc.Public company · 9 yr
    • Director2012 – 2021 · 9 yrNo stock prices for these years
  6. Novavax, Inc.Public company · 2 yr
    • Director2015 – 2017 · 2 yrNo stock prices for these years
  7. Xcel Energy, Inc.Public company · 5 yr
    • Director2012 – 2017 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards2

  • Elevance HealthDirector · 8 yr on the boardNot independent—Paid as an executive
  • TargetDirector · 4 yr on the boardIndependentCompensation & Human Capital Management, Governance & Sustainability—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?